Freedom Leaf, Inc. (OTCMKTS:FRLF), which dually bills itself as ‘The Marijuana Legalization Company®’ has only appeared once before here on Street Register, In an article about Hemp Inc (OTCMKTS:HEMP). HEMP announced it was going to be using the NuAxon Tech Industrial CO2 Supercritical Extractor as part of a joint venture with FRLF.
Today we wanted to focus on FRLF itself, which has just completed a key transaction to increase its cannabis business by a considerable margin, which also happens to come in the wake of the impressive increases the share price has made in recent months.
Freedom Leaf, Inc. (OTCMKTS:FRLF) has reported that it has fully acquired 100% of Green Market Europe S.L. (GME), a Spanish producer of hemp products. Since the initial announcement of the acquisition, (06-28-17), Freedom Leaf Inc. Officers have been diligently working to finalize the international acquisition, and all relevant documentation has been submitted, signed, and finalized.
Clifford J. Perry, Co-founder and CEO of Freedom Leaf Inc., said, “We are very pleased to have completed this transaction, the deal is now final. Our philosophy is to only acquire companies that will add significant Gross Revenue, Net Profit and Shareholder Value to Freedom Leaf Inc. financials, and this is no exception. Green Market Europe S.L. is projected to add $2.393M (USD) in its first full year of operation at approximately a 15% net profit.”
Green Market Europe S.L. facilities include a 21,000 sq. ft. light deprivation greenhouse, a 43,000 sq. ft. indoor growing research facility, and over 200 acres of outdoor production space. The light deprivation allows the increase of the number of yearly crops from 3 to 4 crops a year, and the 43,000 sq. ft. indoor grow facility is used for genetic research and cultivating additional hemp crops. Green Market Europe S.L. is strategically located in Elche, Alicante, an important Spanish business hub, with great year-round weather conditions for agricultural growing and a long tradition of growing hemp.
GME marks the second completed acquisition for Freedom Leaf Inc. in Spain and Europe. The first acquisition was in May 2017 of LaMarihuana.com, the Spanish-speaking community’s leading cannabis portal, and Marihuana-Medicinal.com, an influential Spanish medical cannabis information website. LaMarihuana.com was founded in 2001 and currently has more than 1.7 million page visits monthly, making it the among the most visited online portals worldwide for the Spanish-speaking community. LaMarihuana.com also has more than 1.3 million Facebook fans.
Freedom Leaf, Inc. is currently collaborating with Spanish scientists isolating other rare cannabinoids. Some of the ongoing research includes strains with Tetrahydrocannabivarin (THCV), which suppresses appetite, and Cannabichromene (CBC), which has been shown to aid with depression.
¨GME will be an essential tool of Freedom Leaf to expand in the Medical Cannabis and cannabinoid based therapy. The know-how of mass Cannabinoid production, research and IP gives us a priceless competitive advantage towards cooperating with Governments and Institutions to bring Cannabinoid based therapy to medical patients,” stated by Federico Pando.
Paul F. Pelosi, Jr., Freedom Leaf Inc Chairman of the Board, added, “Freedom Leaf is staking its claim to foreign markets. Starting with Europe and planning for Central and South America expansion as well as other countries around the world. The market for Industrial Hemp is expanding in many countries even faster than the United States, and in many cases even faster than marijuana. Major legal revenue streams are available from exploring these different markets around the world.” (Source: Globe Newswire)
The leap FRLF has taken with the acquisition of GME is a considerable one, and it gives the company a formidable ability to produce not-insignificant quantities of cannabis. We’re going to make sure to follow its progress closely moving forward. Stay locked to Street Register for updates, and we’ll deliver important developments on FRLF as they unfold. In the meantime, if you’ve yet to sign up for our 100% free newsletter, do so now! Just enter your active email address into the box below and submit!
Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in FRLF stock, short or long.